-

Form 8.3 - INTERNATIONAL PAPER COMPANY

LONDON--(BUSINESS WIRE)-- 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Qube Research & Technologies Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

International Paper Company

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

02-08-2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

Yes - DS Smith plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

Common Stock

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.0

7,526,698

2.16

(2) Cash-settled derivatives:

 

0

0.0

0

0.0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

400,000

0.11

0

0

 

TOTAL:

400,000

0.11

7,526,698

2.16

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

0

Details, including nature of the rights concerned and relevant percentages:

0

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (USD)

Common Stock

Sale

5

45.73

Common Stock

Sale

9

45.69

Common Stock

Sale

10

45.06

Common Stock

Sale

11

45.17

Common Stock

Sale

16

45.54

Common Stock

Sale

17

45.47

Common Stock

Sale

34

45.77

Common Stock

Sale

36

45.91

Common Stock

Sale

44

44.92

Common Stock

Sale

50

45.56

Common Stock

Sale

55

45.16

Common Stock

Sale

65

44.98

Common Stock

Sale

70

45.41

Common Stock

Sale

98

45.38

Common Stock

Sale

100

45.16

Common Stock

Sale

100

45.20

Common Stock

Sale

100

45.36

Common Stock

Sale

100

45.37

Common Stock

Sale

100

45.52

Common Stock

Sale

100

45.58

Common Stock

Sale

100

45.63

Common Stock

Sale

100

45.74

Common Stock

Sale

100

45.84

Common Stock

Sale

100

45.94

Common Stock

Sale

106

45.45

Common Stock

Sale

107

45.55

Common Stock

Sale

108

45.20

Common Stock

Sale

112

45.98

Common Stock

Sale

113

45.99

Common Stock

Sale

122

45.59

Common Stock

Sale

147

45.12

Common Stock

Sale

150

45.68

Common Stock

Sale

160

45.11

Common Stock

Sale

200

45.31

Common Stock

Sale

200

45.44

Common Stock

Sale

200

45.45

Common Stock

Sale

200

45.73

Common Stock

Sale

200

45.76

Common Stock

Sale

200

45.77

Common Stock

Sale

200

45.80

Common Stock

Sale

200

45.88

Common Stock

Sale

200

45.93

Common Stock

Sale

205

45.48

Common Stock

Sale

209

44.99

Common Stock

Sale

223

45.08

Common Stock

Sale

226

45.90

Common Stock

Sale

228

45.84

Common Stock

Sale

271

45.68

Common Stock

Sale

273

45.48

Common Stock

Sale

300

45.10

Common Stock

Sale

300

45.34

Common Stock

Sale

300

45.87

Common Stock

Sale

312

45.26

Common Stock

Sale

336

45.03

Common Stock

Sale

368

45.43

Common Stock

Sale

400

45.86

Common Stock

Sale

403

45.55

Common Stock

Sale

405

45.91

Common Stock

Sale

426

45.02

Common Stock

Sale

434

45.07

Common Stock

Sale

468

45.52

Common Stock

Sale

503

44.95

Common Stock

Sale

511

45.15

Common Stock

Sale

520

45.62

Common Stock

Sale

522

45.81

Common Stock

Sale

589

45.06

Common Stock

Sale

608

45.52

Common Stock

Sale

674

45.73

Common Stock

Sale

701

45.83

Common Stock

Sale

717

45.24

Common Stock

Sale

727

45.64

Common Stock

Sale

839

44.97

Common Stock

Sale

867

45.49

Common Stock

Sale

873

45.09

Common Stock

Sale

883

45.53

Common Stock

Sale

907

45.30

Common Stock

Sale

910

45.20

Common Stock

Sale

965

45.00

Common Stock

Sale

979

45.33

Common Stock

Sale

1114

45.19

Common Stock

Sale

1155

45.98

Common Stock

Sale

1156

45.37

Common Stock

Sale

1157

45.01

Common Stock

Sale

1173

45.39

Common Stock

Sale

1231

45.58

Common Stock

Sale

1257

45.21

Common Stock

Sale

1288

45.78

Common Stock

Sale

1301

45.05

Common Stock

Sale

1357

45.34

Common Stock

Sale

1420

45.54

Common Stock

Sale

1449

45.18

Common Stock

Sale

1454

44.98

Common Stock

Sale

1495

45.47

Common Stock

Sale

1501

45.43

Common Stock

Sale

1510

45.79

Common Stock

Sale

1524

45.71

Common Stock

Sale

1614

45.35

Common Stock

Sale

1635

45.31

Common Stock

Sale

1683

45.80

Common Stock

Sale

1706

45.38

Common Stock

Sale

1719

45.48

Common Stock

Sale

1724

45.46

Common Stock

Sale

1769

45.67

Common Stock

Sale

1773

45.66

Common Stock

Sale

1775

45.23

Common Stock

Sale

1782

45.56

Common Stock

Sale

1806

44.96

Common Stock

Sale

1870

45.41

Common Stock

Sale

1920

45.72

Common Stock

Sale

2027

45.04

Common Stock

Sale

2067

45.60

Common Stock

Sale

2173

45.59

Common Stock

Sale

2239

45.63

Common Stock

Sale

2243

45.25

Common Stock

Sale

2319

45.62

Common Stock

Sale

2353

45.42

Common Stock

Sale

2399

45.50

Common Stock

Sale

2568

45.45

Common Stock

Sale

2646

45.65

Common Stock

Sale

2744

45.61

Common Stock

Sale

2890

45.99

Common Stock

Sale

2903

45.77

Common Stock

Sale

2907

45.92

Common Stock

Sale

2913

45.32

Common Stock

Sale

2952

45.22

Common Stock

Sale

3080

45.51

Common Stock

Sale

3122

45.40

Common Stock

Sale

3192

45.29

Common Stock

Sale

3254

45.36

Common Stock

Sale

3254

45.70

Common Stock

Sale

3532

45.57

Common Stock

Sale

3563

45.27

Common Stock

Sale

3608

45.28

Common Stock

Sale

3614

45.76

Common Stock

Sale

3685

45.55

Common Stock

Sale

3802

45.97

Common Stock

Sale

3850

45.85

Common Stock

Sale

3851

45.87

Common Stock

Sale

3919

45.44

Common Stock

Sale

3936

45.75

Common Stock

Sale

4071

45.95

Common Stock

Sale

4340

45.88

Common Stock

Sale

4583

45.89

Common Stock

Sale

4600

45.96

Common Stock

Sale

4844

45.86

Common Stock

Sale

5279

45.84

Common Stock

Sale

5555

45.82

Common Stock

Sale

5576

45.90

Common Stock

Sale

5781

45.74

Common Stock

Sale

9151

45.91

Common Stock

Sale

14733

45.83

Common Stock

Sale

17433

45.93

Common Stock

Sale

110289

45.94

Common Stock

Purchase

5

45.33

Common Stock

Purchase

8

45.23

Common Stock

Purchase

20

45.84

Common Stock

Purchase

22

45.46

Common Stock

Purchase

22

45.88

Common Stock

Purchase

25

45.51

Common Stock

Purchase

28

45.95

Common Stock

Purchase

30

44.96

Common Stock

Purchase

33

45.65

Common Stock

Purchase

34

45.55

Common Stock

Purchase

34

45.98

Common Stock

Purchase

42

45.95

Common Stock

Purchase

46

45.73

Common Stock

Purchase

59

45.97

Common Stock

Purchase

71

45.43

Common Stock

Purchase

78

45.78

Common Stock

Purchase

80

45.05

Common Stock

Purchase

100

45.29

Common Stock

Purchase

100

45.44

Common Stock

Purchase

100

45.74

Common Stock

Purchase

100

45.90

Common Stock

Purchase

105

45.18

Common Stock

Purchase

126

45.36

Common Stock

Purchase

132

45.85

Common Stock

Purchase

154

45.87

Common Stock

Purchase

171

45.76

Common Stock

Purchase

204

45.38

Common Stock

Purchase

250

45.93

Common Stock

Purchase

264

45.45

Common Stock

Purchase

285

45.86

Common Stock

Purchase

297

45.83

Common Stock

Purchase

395

45.40

Common Stock

Purchase

401

45.50

Common Stock

Purchase

438

45.74

Common Stock

Purchase

552

45.49

Common Stock

Purchase

631

45.77

Common Stock

Purchase

740

45.75

Common Stock

Purchase

1035

45.72

Common Stock

Purchase

1237

45.48

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. call option

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of securities

Exercise price per unit (USD)

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (USD)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

0

0

0

0

 

0

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

0

 

0

0

0

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

05-08-2024

Contact name:

Stuart Brown

Telephone number:

00442070722969

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Full name of person making disclosure:

Qube Research & Technologies Limited

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

International Paper Company

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Common Stock

Call option

IP US 09/20/24 C50 Equity

Purchase

120,000

USD 50

American

09/20/24

Common Stock

Call Option

IP US 09/20/24 C50 Equity

Purchase

280,000

USD 50

American

09/20/24

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Contacts

Qube Research & Technologies LTD

Qube Research & Technologies LTD

LSE:0JCB

Release Versions

Contacts

Qube Research & Technologies LTD

More News From Qube Research & Technologies LTD

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
Back to Newsroom